Network Profiles Matt Outten

(1 - 11 from 13
)

BridgeBio's Origin Enters Partnership with Medison

bridgebio.com
... make fosdenopterin available to infants and children suffering from MoCD Type A,” said Matt Outten, Chief Commercial Officer at BridgeBio.
+1